Lexapro, an anti-depressant drug that is meant to lessen the stress that leads to heart ailments and this is according to a clinical trial made in Duke University. Emotional stress can really lead to serious coronary heart ailment. For example, there are case studies conducted among 2 natural calamities, these are hurricane Katrina & the earthquake in Japan last 2011. There are records that show that there are numbers of heart attack incidents the following months after the calamities. Doctors now recognize emotional pressure as a trigger to heart ailments and this is known to be mental stress induced myocardial ischemia or better known as MSIMI. There are 3 out of 4 patients with coronary heart ailment that are prone to MSIMI.

Understanding MSIMI

MSIMI may lessen the quantity of blood & oxygen levels in the body that stretches the heart muscles that prevents it from working in its maximum capability. MSIMI is also linked with increased danger of heart attack that can lead to death. Given the association amongst psychological and cardiac wellbeing, experts now think if an antidepressant such as selective serotonin reuptake inhibitors can help in preventing heart ailments from taking place. There are studies in the past concerning disheartened people who took SSRI and they have seen mixed results, while some reports show that there are no effects seen in the function of the heart. Other reports say that it can help in lowering the risk of having a heart attack that could lead to death.

Further studies with Lexapro

It was Dr. Jiang & his contemporaries who directed SSRI Lexapro to people with heart ailments. This is to understand if it can help in lessening anxiety persuaded cardiac damage. Lexapro is usually administered to a patient to cure hopelessness & nervousness issues among adults. Those with coronary heart disease were also given with Lexapro for 6 weeks and these are adults of 64 years old. They were also given with sequences of psychological pressure test. Around 127 of them completed the tests. Sixty four were induced with Lexapro whereas sixty three were given the placebo. The patients volunteered for this study, but they do not have the idea if they were given a sugar pill or an anti-depressant.
There are heart exams that showed that the anti-depressant was able to lessen the MSIMI in 1/2, with thirty four point two percent of the patients taking Lexapro are free from the condition vs. the seventeen point five percent of those who took the placebo. Those with unchanging heart ailments were picked for this particular case study, due to sensible amounts of mental stress that will not be risky to their general wellbeing condition.
There may be insinuations for accepting the passageways wherein the negative emotions truly affect the cardiovascular prognosis.